# DOJ Resolves $20.5M HRSA Billing Case

On September 30, 2026, Signal Diagnostics LLC agreed to pay the United States $20.5 million to resolve False Claims Act allegations involving overpayments from HRSA’s COVID-19 Uninsured Program. DOJ alleged the company failed to return payments for claims involving patients who had insurance; the settlement resolves the allegations without a determination of liability. For organizations billing or administering federal healthcare programs, the case underscores the importance of eligibility controls, internal audits, and timely repayment of identified overpayments.

- Healthcare providers and contractors handling federal program claims should review how insurance status is verified and how potential overpayments are identified, escalated, and repaid.
- The matter involved DOJ, HRSA, and HHS-OIG, highlighting federal scrutiny of billing and program-integrity practices tied to healthcare funding.
- Organizations serving federal healthcare programs can use the allegations as a prompt to assess whether their billing and audit processes address claims submitted for patients who may not meet program eligibility criteria.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Regulatory Compliance
**Published:** September 30, 2026

### Government Entities
- U.S. Department of Justice (DOJ)
- Health Resources & Services Administration (HRSA)
- U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG)

### Vendors
- Signal Diagnostics LLC (settling party)

### Key Quotes
> By knowingly avoiding repayment of overpayments, Signal Diagnostics undermined the integrity of a program designed to support uninsured patients during a national public health emergency.
> — Miranda L. Bennett, Acting Deputy Inspector General for Investigations

> When companies knowingly retain federal healthcare program funds they were not entitled to receive, they violate the public’s trust and the law.
> — Brett A. Shumate, Assistant Attorney General

### Sources
- [ Office of Public Affairs |  Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program | United States Department of Justice](https://www.justice.gov/opa/pr/signal-diagnostics-agrees-pay-over-20m-settle-false-claims-act-allegations-failing-refund) - DOJ